Patients with early, vague symptoms, were the clinicians suspects, or wants to rule out, pancreatic cancer.
The early symptoms of pancreatic cancer are often vague, and include back pain, stomach pains, digestive problems, fatigue, unexplained weight loss or onset jaundice. This makes the disease difficult to detect.
Because of this, it takes 6–9 months and 18 visits to the doctor on average, before a patient with pancreatic cancer is actually diagnosed with cancer. The delay may cause the patient to go from treatment to non-treatable pancreatic cancer.
Testing for pancreatic cancer in risk groups with early, vague symptoms with IMMray™ PanCan-d could help clinicians to diagnose the cancer while it is still resectable by surgery, thereby dramatically improving survival rates, and at the same time lowering healthcare costs.
In order to influence medical practice and national guidelines, Immunovia is working actively on a global basis with Key Opinion Leaders (KOL) (Read more about PanSYM-1) The goal is to achieve routine testing of patients with early, vague symptoms were the clinician suspects – or wants to rule out – pancreatic cancer.
- Fiona M Walter, Katie Mills, Silvia C Mendonça, Gary A Abel, Bristi Basu, Nick Carroll, Sue Ballard*, John Lancaster*, William Hamilton, Greg P Rubin, Jon D Emery, “Symptoms and patient factors associated with diagnostic intervals for pancreatic cancer (SYMPTOM pancreatic study): a prospective cohort study”, Lancet Gastroenterol Hepatol 2016.
- ACE Cancer Decision Support Tools Cluster “Using Cancer Decision Support Tools to support the early diagnosis of cancer”, May 2017
- Suresh T. Chari, MD,* et al Department of Medicine, Mayo Clinic, Rochester, MN, Summative Review: “Early Detection of Sporadic Pancreatic Cancer”, Volume 00, Number 00, Month 2015